Skip to main content
Caplight Logo









SiftMed

SiftMed

Private
CanadaHealthcare & Life Scienceshttps://www.siftmed.ca/

Last Round

Grant

Jul 8, 2025

Total Funding Raised

$3.39M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

SiftMed is a health tech company that provides an AI-powered platform designed to organize, analyze, and review unstructured medical records.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Legal Tech, InsurTech, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

intelligent document processingIDPmedical record analysislegal techinsurtechmedical AIclaims processingdocument automationAI summarizationhealth techSaaSmedical record reviewAI scribelegal automationdata extraction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SiftMed Comparables

Compare SiftMed with similar companies based on industry and business-model similarity.

SiftMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wisedocs
86%
InQuery
83%
Tavrn
78%

SiftMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 8, 2025
GrantDec 21, 2023
GrantFeb 7, 2023
SeedFeb 7, 2023

Key People

Founding team and executive leadership

Zackary Chaulk

Chief Privacy Officer Head Of Product

Executive Team

SiftMed Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 128% MoM, reaching 6.8K.

  • Jun 17, 2026

    Monthly visitors increased 955% MoM, reaching 5K.

Recent news

Latest coverage and updates

  • has_revenueAug 10, 2026

    SiftMed Inc. had revenue of $7.5M on Sep 1st '25.

  • is_developingJul 20, 2026

    SiftMed Inc. is developing AI software on Jul 20th '26.

  • receives_financingJul 17, 2026

    SiftMed Inc. received financing of $3.57M in Seed on Jul 17th '26.

SiftMed Filings

Explore SEC and related filing metadata, where available.

SiftMed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SiftMed's valuation, stock price, and market status.

Is SiftMed a public or private company?

SiftMed is a private company.

What is the current stock price of SiftMed?

SiftMed is a private company with no public stock price. No recent secondary market data is available.

How much is SiftMed worth (valuation)?

Valuation information for SiftMed is not publicly available.

Can I buy SiftMed stock?

SiftMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SiftMed's last funding round?

SiftMed's most recent funding round was Grant on December 21, 2023.

Who are the main investors in SiftMed?

Key investors in SiftMed include Government of Newfoundland and Labrador, Atlantic Canada Opportunities Agency, Pelorus Venture Capital.

Will SiftMed IPO soon?

No public IPO plans have been announced for SiftMed.

How can I track SiftMed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SiftMed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCanada
Employee Range47
Year Founded2020
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?